The TRPM1 gene helps relay light signals inside the retina, the light sensing tissue at the back of the eye, so your brain can interpret what you see. This gene plays an important role in night vision and also supports normal signaling in certain skin pigment cells. If the gene does not work properly, especially when both copies carry certain harmful variants, it can cause congenital stationary night blindness, which often means trouble seeing in dim light from birth and may also include reduced visual sharpness or unusual eye movements.
What is a gene?
Genes are pieces of DNA that carry instructions your cells use to make molecules or direct activities in the body. Some genes provide the information needed to produce proteins, which are the working parts of cells. Others mostly regulate when certain processes happen, where they take place, and how strongly they run. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
TRPM1Gene function
What if the gene works
The TRPM1 gene helps certain retinal cells pass along signals needed for normal vision, especially in dim light. It also supports skin cells called melanocytes, which make pigment.
Risk
What if the gene does not work
TRPM1 gene variants can cause congenital stationary night blindness, with lifelong trouble seeing in dim light. Milder and more severe variants may affect how much vision is reduced and whether nystagmus or nearsightedness are also present.
Treatment
What does that mean for your treatment
No established treatment or drug choice currently depends on a pathogenic variant in the TRPM1 gene. The TRPM1 gene is being studied in inherited retinal disease research, but this has not yet led to a gene directed therapy.
Gene function
What if the gene works
TRPM1 helps certain cells turn tiny changes at their surface into useful signals. Its best known jobs are in the retina, where it supports vision, and in pigment cells, where it helps with normal cell activity. When it is working properly, these cells can communicate in a steady, well-timed way.
The TRPM1 gene makes a channel that lets positively charged particles, including calcium, move across cell membranes. This controlled flow helps cells switch electrical signals on and off and supports routine cell communication.
In the retina, TRPM1 helps a group of nerve cells called ON bipolar cells respond after light is detected. This is a key part of what the TRPM1 gene does in the eye, especially for seeing in dim light and noticing contrast.
TRPM1 is also active in melanocytes, the cells that make melanin. It supports calcium signaling in these cells and helps them carry out normal pigment-related work.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant changes how a gene works more significantly and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TRPM1 gene can change the shape of its channel protein, reduce how much reaches the cell surface, or keep it from opening properly in retinal cells that pass light signals forward, which helps explain how TRPM1 gene variants affect night vision. Some variants leave partial activity, while more disruptive variants can largely shut the channel down. That larger loss of function is often linked to earlier or more noticeable features of congenital stationary night blindness.
How variants are linked to conditions
Pathogenic variants in the TRPM1 gene cause complete congenital stationary night blindness, an inherited eye condition present from birth. This TRPM1 gene night blindness link is well established in human genetics. People with this condition often have lifelong trouble seeing in dim light, and some also have reduced visual sharpness, nearsightedness, or involuntary eye movements.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and are simply part of natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the TRPM1 gene. If a disease-causing change is present, the main factor is the genetic change itself, and a doctor or genetic counselor can help explain what that may mean for you or your family.
Inheritance of TRPM1 variants
TRPM1-related vision changes are usually inherited in an autosomal recessive pattern. This means a child needs to inherit two nonworking copies of the TRPM1 gene, one from each parent, to have the condition. Parents who each carry one TRPM1 variant are typically unaffected carriers, and with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. In practical terms, how TRPM1 variants are inherited usually involves both sides of the family, even when no one else has noticed symptoms.
What does my TRPM1 result mean for my family?
For TRPM1, the best-known inherited condition is a form of lifelong night blindness that usually runs in families in a recessive way. This often means both parents are healthy carriers, and brothers or sisters may also be affected or be carriers even if they seem fine in daylight. Other close relatives may also carry the gene change, which can matter for family planning.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the TRPM1 gene, genetic testing uses a blood or saliva sample. TRPM1 genetic testing reads the gene’s DNA code to find variants that may help explain inherited vision conditions, especially night vision problems, and results are interpreted alongside eye exams and family history.
When should I consider getting a genetic test?
Testing for changes in the TRPM1 gene may be worth considering if poor vision in dim light began in infancy or childhood, especially along with shaky eye movements, strong nearsightedness, or a family history of similar eye problems. A TRPM1 result can help confirm an inherited condition that affects how the eye responds in low light.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains varies with the condition and the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those influenced by many genes, genetic information provides context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body handles certain medicines, which helps explain why the same treatment works well for one person but less well for another. Some gene differences affect how quickly a drug is broken down or moved through the body. These differences are common and can shape how much benefit you get from a medicine or how sensitive you are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It looks at relationships between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medicines, genes can influence how strong a drug’s effects are or how the body handles it. This information can support more informed, more individualized treatment decisions. If you want to learn more about this topic, you can explore it further in the LearnHub.
Drugs influenced by the TRPM1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general questions about side effects, new symptoms, or how medicines may affect you are best discussed with your doctor.
History
The TRPM1 gene first drew attention in the late 1990s during melanoma research, when scientists noticed that its activity was often lower in more aggressive tumors. It was initially called melastatin because of that connection to melanoma. From these first observations, research expanded steadily. As the field moved forward, the TRPM1 gene was reclassified as part of the TRP family of genes, a larger group studied across many areas of biology. Later work linked variants in the TRPM1 gene to a form of inherited night blindness, which broadened medical interest beyond cancer research. This shift helped turn TRPM1 from a niche research finding into a gene with recognized clinical importance.